Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study

Ford, Alexander C.; Forman, David; Bailey, Alastair G.; Axon, Anthony I. R.; Moayyedi, Paul
March 2007
Gut;Mar2007, Vol. 56 Issue 3, p321
Academic Journal
Background: Numerous studies examining the prevalence and natural history of dyspepsia in the general population have been conducted. However, few have reported the effect of quality of life on the development of dyspepsia. A 10-year longitudinal follow-up study examining the effect of quality of life on subsequent dyspepsia was performed. Methods: Individuals originally enrolled in a population-screening programme for Helicobacter pylon were contacted through a validated postal dyspepsia questionnaire. Baseline demographic data, quality of life at original study entry, and dyspepsia and irritable bowel syndrome (IBS) symptom data were already on file. Consent to examine primary-care records was sought, and data regarding non-steroidal anti-inflammatory drugs (NSAID) and aspirin use were obtained from these. Results: Of 8407 individuals originally involved, 3912 (46.5%) provided symptom data at baseline and 10- year follow-up. Of 2550 (65%) individuals asymptomatic at study entry, 717 (28%) developed new-onset dyspepsia at 10 years, an incidence of 2.8% per year. After multivariate logistic regression, lower quality of life at study entry (OR 2.63; 99% CI 1 .86 to 3.71), higher body mass index (OR per unit 1 .05; 99% CI 1 .02 to 1.08), presence of lBS at study entry (OR 3.1; 99% Cl 1.51 to 6.37) and use of NSAIDs and/or aspirin (OR 1 .32; 99% Cl 0.99 to 1 .75) were significant risk factors for new-onset dyspepsia. Conclusions: The incidence of new-onset dyspepsia was almost 3% per year. Low quality of life at baseline exerted a strong effect on the likelihood of developing dyspepsia at 10 years.


Related Articles

  • Who Consults With Dyspepsia? Results from a Longitudinal 10-Yr Follow-Up Study. Ford, Alexander C.; Forman, David; Bailey, Alastair G.; Cook, Michael B.; Axon, Anthony T.R.; Moayyedi, Paul // American Journal of Gastroenterology;May2007, Vol. 102 Issue 5, p957 

    OBJECTIVE: Dyspepsia is common, and the condition is often chronic, with a relapsing and remitting nature. Factors influencing the decision to consult a physician with symptoms remain unclear. METHODS: The authors conducted a 10-yr follow-up longitudinal survey of individuals originally involved...

  • ERADICATE THE BUG BEFORE YOU START THE DRUG? Metz, David C.; Johnson, David // American Journal of Gastroenterology;Feb1998, Vol. 93 Issue 2, p279 

    Presents a commentary about a randomized trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug (NSAID) therapy to prevent peptic ulcers. Evaluation and treatment of patients with nonulcer dyspepsia; Controversy regarding strategies for primary prevention of...

  • Dyspepsia. Sadowski, Daniel C.; van Zanten, Sander Veldhuyzen // CMAJ: Canadian Medical Association Journal;3/3/2015, Vol. 187 Issue 4, p276 

    The article presents several facts about dyspepsia. Topics include the preference for endoscopy as diagnostic modality if alarm symptoms are present, use of nonsteroidal anti-inflammatory drugs by up to 30% of patients with dyspepsia in a Canadian population, and the need for patients with...

  • Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Ford, Alexander C.; Marwaha, Avantika; Sood, Ruchit; Moayyedi, Paul // Gut;Jul2015, Vol. 64 Issue 7, p1049 

    Objectives Many cross-sectional surveys have reported the prevalence of uninvestigated dyspepsia, but there has been no recent systematic review of data from all studies to determine its global prevalence and risk factors. Design MEDLINE, EMBASE and EMBASE Classic were searched (until January...

  • Značaj Helicobacter pylori infekcije i nesteroidnih antiinflamatornih lekova kod bolesnika sa krvarenjem iz gornjeg dela gastrointestinalnog trakta. Golubović, Gradimir; Tomašević, Ratko; Radojević, Biljana; Pavlović, Aleksandar; Dugalić, Predrag // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Jul2007, Vol. 64 Issue 7, p445 

    Background/Aim. Helicobacter pylori (H. pylori) infection and nonsteroidal anti-inflammatory drugs (NSAIDs) use are considered to be the most important risk factors having influence on the onset of bleeding gastroduodenal lesions. Whether there is an interaction between H. pylori infection and...

  • Effect of Helicobacter pylori Infection on the Severity of Gastroduodenal Mucosal Injury after the Acute Administration of Naproxen or Aspirin to Normal Volunteers. Lanza, Frank L.; Evans, Dolores G.; Graham, David Y. // American Journal of Gastroenterology;Jun1991, Vol. 86 Issue 6, p735 

    This study asked whether Helicobactor pylori infection accentuated the severity of NSAID-induced mucosal injury of the stomach or duodenum. We evaluated the severity of acute mucosal injury and H. pylori status in 61 normal volunteers (ages 22-43 yr) receiving naproxen (1000 mg, n = 30) or...

  • Genotypes of Helicobacter pylori Obtained From Gastric Ulcer Patients Taking or Not Taking NSAIDs. Li Li; Kelly, Lisa K.; Ayub, Kamran; Graham, David Y.; Go, Mae F. // American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1502 

    OBJECTIVE: Whether Helicobacter pylori infection and use of nonsteroidal antiinflammatory drugs (NSAIDs) are independent risk factors for ulcerogenesis remains unclear. We undertook this study to evaluate H. pylori isolates from gastric ulcer patients to determine whether the...

  • H. pylori infection and risk of NSAID-induced ulcers. Walling, Anne D. // American Family Physician;6/1/1998, Vol. 57 Issue 11, p2857 

    Presents information pertaining to the medical factors involving the risk of the nonsteroidal anti-inflammatory drugs (NSAIDs) towards the Helicobacter pylori infection. Reference to the random assignment of patients; Effects of this infection; Completion of a disease activity index.

  • Helicobacter pylori infection common in ulcer patients.  // Cortlandt Forum;02/25/99, Vol. 12 Issue 2, p15 

    Informs that chronic Helicobacter pylori infection has been increasingly associated with gastric and duodenal ulcers unrelated to nonsteroidal anti-inflammatory drugs (NSAID). Role of H. pylori infection in the pathogenesis of nonulcer dyspepsia, particularly in users of NSAID.


Read the Article


Sign out of this library

Other Topics